Zheng, W., Miao, K., Liu, Y. et al. (2010). Chemical diversity of biologically active metabolites in the sclerotia of Inonotus obliquus and submerged culture strategies for up-regulating their production. Appl Microbiol Biotechnol87: 1237. DOI: 10.1007/s00253-010-2682-4.
Song, Y., Hui, J., Kou, W. et al. (2008). Identification of Inonotus obliquus and Analysis of Antioxidation and Antitumor Activities of Polysaccharides. Curr Microbiol57: 454. DOI: 10.1007/s00284-008-9233-6.
Tepkeeva, I.I., Moiseeva, E.V., Chaadaeva, A.V. et al. (2008). Evaluation of antitumor activity of peptide extracts from medicinal plants on the model of transplanted breast cancer in CBRB-Rb(8.17)1Iem mice. Bull Exp Biol Med145: 464. DOI: 10.1007/s10517-008-0119-1.
Zhong, X., Ren, K., Lu, S. et al. (2009). Progress of research on Inonotus obliquus. Chin. J. Integr. Med.15: 156. DOI: 10.1007/s11655-009-0156-2.
Shashkina, M.Y., Shashkin, P.N. & Sergeev, A.V. (2006). Chemical and medicobiological properties of chaga (review). Pharm Chem J40: 560. DOI: 10.1007/s11094-006-0194-4.
Godugu C, Patel AR, Doddapaneni R, Somagoni J, Singh M (2014). Approaches to Improve the Oral Bioavailability and Effects of Novel Anticancer Drugs Berberine and Betulinic Acid. PLoS ONE9 (3): e89919. DOI: 10.1371/journal.pone.0089919.
Park YM, Won JH, Kim YH, Choi JW, Park HJ, Lee KT. (2005). In vivo and in vitro anti-inflammatory and anti-nociceptive effects of the methanol extract of Inonotus obliquus. J Ethnopharmacol.101 (1-3): 120-8. PMID15905055.
Mi Ja Chung, Cha-Kwon Chung, Yoonhwa Jeong, and Seung-Shi Ham (2010). Anticancer activity of subfractions containing pure compounds of Chaga mushroom (Inonotus obliquus) extract in human cancer cells and in Balbc/c mice bearing Sarcoma-180 cells. Nutr Res Pract.4 (3): 177–182. PMC2895696.
Wenner CA, Martzen MR, Lu H, Verneris MR, Wang H, Slaton JW. (2012). Polysaccharide-K augments docetaxel-induced tumor suppression and antitumor immune response in an immunocompetent murine model of human prostate cancer.. Int J Oncol.40 (4): 905-913. PMC3584555.
